Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Cylene Pharmaceuticals, Inc. is a privately-held pharmaceutical company dedicated to the discovery, development and commercialization of first-in-class small molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. Cylene’s pipeline is led by CX-3543, a VEGF/c-Myc Oncogene Inhibitor currently in preclinical development. CX-3543 and other molecules in the pipeline originate from the company’s proprietary platform, which directs small molecules at molecular targets that regulate the expression of key oncogenes. The company is establishing its leadership position in small molecule regulation of oncogene expression by commercializing the pioneering work of two Cylene founders, Professors Laurence Hurley and Daniel Von Hoff. ( www.cylenepharma.com )
Cylene Pharmaceuticals , Inc.
5820 Nancy Ridge Drive Suite 200
San Diego, California 92121
USA
Tel: (858) 875-5100
Fax: (858) 875-5101